Viewing Study NCT04162366


Ignite Creation Date: 2025-12-24 @ 4:11 PM
Ignite Modification Date: 2025-12-27 @ 2:11 AM
Study NCT ID: NCT04162366
Status: WITHDRAWN
Last Update Posted: 2022-11-23
First Post: 2019-11-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Research Study to Show Aprocitentan is Efficacious and Safe to Treat Patients With Uncontrolled Blood Pressure and Chronic Kidney Disease.
Sponsor: Idorsia Pharmaceuticals Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ID-080A305
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View